Clinical Trial Update: Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating sodium salicylate in patients with advanced myelodysplastic syndromes, acute myeloid leukemia, or chronic lymphocytic leukemia has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Sodium salicylate (sodium salicylate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED